News

Arbele Triumphs at Annual Biomedical Pitch Competition

Arbele Triumphs at Annual Biomedical Pitch Competition

Arbele's Remarkable Victory at the Annual Biomedical Pitch Competition

Arbele Limited, a pioneering biotech company based in Hong Kong, recently achieved a significant milestone by winning first place at the prestigious 4th Biomedical Pitch Competition organized by the Boston Capital Investment Club (BCIC). With over 170 competitors from various parts of the globe, Arbele distinguished itself through its innovative research in CDH17-targeted immunotherapy and antibody-drug conjugate (ADC) technology.

The company is dedicated to advancing novel therapies for gastrointestinal cancers by specifically targeting cadherin-17 (CDH17), a marker that is prominently expressed in malignancies affecting the digestive tract. Among its crown jewels is Cabotamig (ARB202), a groundbreaking T-cell engager designed to simultaneously bind to CDH17 and CD3, aimed at offering treatment for a wide range of gastrointestinal cancers. This promising therapy has exhibited high safety regarding tumor targeting and improved survival outcomes in patients with challenging medical backgrounds resembling other T-cell engagers noted in Phase I clinical studies.

Beyond just Cabotamig, Arbele is furthering its research with multiple ADC programs that include biparatopic and bispecific targets combined with novel dual payloads. The company is preparing for planned regulatory submissions in both the U.S. and China, reinforcing its commitment to bring advanced treatments to market. The judges at the competition praised Arbele's innovative platform for effectively balancing tumor targeting specificity while minimizing the potential for off-target toxicity, highlighting its readiness for real-world clinical application.

The event featured inspiring keynote addresses from industry leaders, including Mr. Albert Wong, CEO of the Hong Kong Science and Technology Parks Corporation (HKSTP). He shared valuable insights regarding the ongoing growth of Hong Kong's biomedical ecosystem and cross-border innovations. Dr. Qiusong Tang, Head of the Roche Accelerator, also provided perspective on the importance of scalable startups and external innovation strategies within reputable organizations like Roche.

Intense Competition with Global Implications

The impressive turnout at the 2025 competition, which saw over 170 applications, culminated in 17 finalist teams. Arbele's achievement not only symbolizes substantial international acknowledgment for its CDH17-targeting platform but also fuels its fundraising, regulatory, and commercialization initiatives.

Since its inception in 2022, the competition has facilitated impressive investments surpassing $100 million, marking a significant impact on the biotech landscape.

Overview of Arbele

Arbele Limited is on the forefront as a clinical-stage biotechnology company, dedicated to developing revolutionary first-in-class and best-in-class immunotherapies aimed at combating digestive tract cancers. With a focused commitment to CDH17-targeted T-cell engagers and ADCs, Arbele aspires to enhance survival rates among patients with limited treatment alternatives.

About BCIC

The Boston Capital Investment Club (BCIC) serves as a vital connector for early-stage companies and over 300 institutional and angel investors on a global scale. With extensive expertise in areas such as business development, incubation, and establishing strategic partnerships, BCIC has solidified its status as one of North America’s foremost unified cross-border investment platforms.

For Press Contact:
Dr. Diana Hay

For BD & Partnering Inquiries:
Mr. Alex Wang

Frequently Asked Questions

What recent recognition did Arbele achieve?

Arbele recently won first place in the 4th Biomedical Pitch Competition organized by the Boston Capital Investment Club.

What is Arbele developing?

Arbele is focused on developing innovative treatments for gastrointestinal cancers using CDH17-targeted therapies.

Who were the keynote speakers at the competition?

Keynote speakers included Mr. Albert Wong from HKSTP and Dr. Qiusong Tang from Roche.

How many companies competed in the competition?

Over 170 companies applied for the competition, with 17 finalists selected.

What is the mission of Arbele?

Arbele aims to improve survival outcomes for patients with limited treatment options through advanced immunotherapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cambrian Turns Dairy Wastewater Into Long-Term Gas

Updated Category News Views 52

A Wisconsin dairy plant just traded lagoon duty for a 20-year service arrangement, and that is more consequential than the usual shiny renewable-gas headline. Cambrian Innovation says it has commissioned and is operating a wastewater treatment and resource recovery system that handles roughly 280,000 gallons a day. That works out to about 102 million gallons annually, a...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 182

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
Skanska Adds $80M U.S. Tech Facility Contract to Orders

Updated Category News Views 149

An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...

Continue Reading
ZAKSIMLAB Tests Kombucha and Salmon Snack Pairing in Cafes

Updated Category News Views 202

A fish-based chip beside a fizzy tea mix is an odd little commercial wager, and that is exactly why ZAKSIMLAB's latest move deserves a look. The Seoul food brand launched Salmon Crunch Protein Chips in September, then put the snack next to its powdered kombucha at the 2026 Cafe & Bakery Fair Season 2. This is not a grand earnings story; no sales, pricing, store-count, or...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 111

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Mantle's Japan Listing Puts $MNT Through a Real Test

Updated Category News Views 163

Japan's crypto gatekeepers just handed Mantle a key, not a crown. The November 18 listing of $MNT on GMO Coin is a meaningful operational win because getting onto a Japanese centralized exchange is not the usual loose-change exercise seen in friendlier jurisdictions. Mantle cleared a review process involving GMO Coin and the Japan Virtual and Crypto Assets Exchange...

Continue Reading
Housing's Value Equation Is Getting More Complicated

Updated Category News Views 64

A homeowner's insurance bill has become a louder market signal than a granite countertop. Green Builder Media's latest batch of research, publishing and events is aimed squarely at that uncomfortable truth: housing is no longer judged only by the price on the contract. Buyers, builders, lenders and insurers are being pushed to reckon with what a home costs to own, protect...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 0

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
BD&J's Workplace Recognition Meets Los Angeles Growth Test

Updated Category News Views 58

A workplace award is not a verdict from a jury, but it can still tell you where a law firm is putting its money and attention. BD&J Injury Lawyers landed on the Los Angeles Business Journal's 2026 list of most admired law firms to work for, announced November 18. For a personal-injury practice trying to deepen its footing in a brutally crowded Los Angeles market, that is...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading

Top 5 Most Recently Viewed Articles

Delta Air Lines and Taiwan Semiconductor: Earnings Insights

Updated Category News Views 120

Delta Air Lines: Anticipated Earnings Report As we look ahead to the earnings season, all eyes are on Delta Air Lines. Sales projections indicate a modest increase of 0.8%, yet analysts predict a significant downturn of 15.2% in earnings. Despite some downward adjustments from analysts, Delta boasts an impressive history of surprising on earnings. Delta operates multiple...

Continue Reading
Vera Bradley Sees Share Price Decline Amid Revenue Challenges

Updated Category News Views 153

Vera Bradley Experiences Revenue Challenges Amid Market Pressures Vera Bradley, Inc. (NASDAQ: VRA) has recently faced a noteworthy drop in its stock price, which sank by 12.65% in premarket trading. This decline followed the company's second-quarter earnings report that, although it surpassed expectations, revealed that revenue fell short of what analysts had predicted....

Continue Reading
Organon's Q4 Earnings Results: Key Highlights for Investors

Updated Category News Views 188

Understanding Organon's Q4 Earnings Results Organon (NYSE: OGN) has recently shared its earnings report, revealing critical insights that every investor should consider. The report reflects the company's financial health and performance trends over the last quarter, helping stakeholders make informed decisions. Earnings Overview In a notable announcement, Organon reported...

Continue Reading
Expanding Mental Health Services: Ana Deeter Joins Relief

Updated Category News Views 222

Expanding Mental Health Services at Relief Mental Health Relief Mental Health is excited to announce the addition of Ana Deeter, PA-C, to their team at the Northbrook clinic. Deeter, who is a board-certified physician assistant, will enhance the clinic's psychiatric services and offer SPRAVATO® (esketamine) treatment to adults seeking support. A New Specialist for...

Continue Reading
Discover BLUETTI's Cutting-Edge Energy Innovations at CES 2026

Updated Category News Views 245

Revolutionizing Energy Solutions with BLUETTI At this year's CES, BLUETTI, a leader in energy storage solutions, introduced an array of revolutionary products under the theme 'Innovate for All'. These innovations cater to the diverse demands of modern living, providing freedom and resilience for homes, vehicles, and the planet. Key Innovations from BLUETTI As BLUETTI...

Continue Reading